Based on SEC filing data. A biotech corporation based in San Diego has raised $41.9 million in equity funding and is operating at the growth stage. The company is advancing its biotech initiatives with this capital infusion.
Get notified the moment Neurana Pharmaceuticals, Inc. files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.